ACTA NEUROPATHOLOGICA

期刊基本信息

  • 期刊名称:ACTA NEUROPATHOLOGICA
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore)
  • 期刊ISSN:0001-6322
  • 期刊EISSN:1432-0533
  • 简称:ACTA NEUROPATHOL
  • 影响因子:9.3
  • 实时影响因子:截止2025年5月19日:9.226
  • 五年影响因子:11.6
  • JCI期刊引文指标:3.12
  • h-index:146
  • 2024-2025自引率:6.50%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:https://www.editorialmanager.com/aneu/
  • 是否OA开放访问:No
  • 出版商:Springer Berlin Heidelberg
  • 出版年份:1961

ACTA NEUROPATHOLOGICA

Science Citation Index Expanded (SCIE)Scopus (CiteScore)

期刊介绍

Acta Neuropathologica aims to publish the best papers on pathology of neurological disease, as well as experimental studies on molecular and cellular mechanisms using in vitro and in vivo models, ideally validated by analysis of human tissues.

The journal publishes Original Papers, Review Articles, Case Reports, and Scientific Correspondence (Letters).

Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identiy of the subjects under study should be omitted.

Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 86-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.

The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements.

期刊语言要求

Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

投稿要求

CITESCORE

CiteScoreSJRSNIPCiteScore排名
17.904.4832.244
学科分区排名百分位
大类:Neuroscience
小类:Cellular and Molecular Neuroscience
Q15 / 100
95%
大类:Neuroscience
小类:Neurology (clinical)
Q19 / 400
97%
大类:Neuroscience
小类:Pathology and Forensic Medicine
Q12 / 204
99%

WOS期刊JCR分区

WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:CLINICAL NEUROLOGYSCIEQ18/285
97.4%
学科:NEUROSCIENCESSCIEQ116/314
95.1%
学科:PATHOLOGYSCIEQ13/90
97.2%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:CLINICAL NEUROLOGYSCIEQ17/285
97.72%
学科:NEUROSCIENCESSCIEQ19/314
97.29%
学科:PATHOLOGYSCIEQ13/90
97.22%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区3区
CLINICAL NEUROLOGY
临床神经病学
3区4区1区
NEUROSCIENCES
神经科学
4区1区1区
PATHOLOGY
病理学
1区3区1区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 1区1区1区
CLINICAL NEUROLOGY
临床神经病学
2区4区1区
NEUROSCIENCES
神经科学
3区3区1区
PATHOLOGY
病理学
1区1区1区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友